LCN2 and prostate cancer: In conjunction with our observations on the secretion of VEGF and NGAL described above, this could also indicate a tendency toward a less-aggressive phenotype, as CDH1 is a tumor suppressor gene, and inactivation of E-cadherin is involved in the development of prostate cancer [76,77].